Orthopediatrics director granted 11,436 KIDS shares

ORTHOPEDIATRICS CORP director Kelly Laine Fischer received a stock-based compensation grant.

Rhea-AI Filing Summary

ORTHOPEDIATRICS CORP director Kelly Laine Fischer received a stock-based compensation grant. On June 9, 2026, Fischer was awarded 11,436 shares of Common Stock at $0.00 per share, reported as a grant or other acquisition rather than an open-market purchase.

Following this award, Fischer’s directly held position totals 15,781 shares, which the filing notes includes restricted stock awards. The transaction reflects routine equity compensation for a director and does not represent a discretionary market trade in the company’s shares.

Insights

Equity compensation analyst

Routine director equity grant, not an open-market trade.

The report shows Kelly Laine Fischer, a director of ORTHOPEDIATRICS CORP, receiving 11,436 shares of Common Stock at $0.00 per share as a grant or award. This is standard stock-based compensation rather than a purchase.

After the grant, Fischer holds 15,781 shares, and the footnote confirms this total consists of restricted stock awards. With no derivative positions listed and no sale activity, this filing mainly updates the director’s equity-based pay and ownership, carrying limited informational value about sentiment.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 1 txn

Insider Fischer Kelly Laine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00

Holdings After Transaction: Common Stock — 15,781 shares (Direct)

Footnotes (1)

1. F1. Includes restricted stock awards totaling 15,781 shares.

Key Figures

Shares granted: 11,436 shares Grant price: $0.00 per share Shares held after grant: 15,781 shares +2 more

5 metrics

Shares granted 11,436 shares Common Stock grant reported on June 9, 2026

Grant price $0.00 per share Equity award to director classified as compensation

Shares held after grant 15,781 shares Director’s direct Common Stock holdings following transaction

Transaction direction Acquire (grant/award acquisition) SEC transaction code A for equity award

Security type Common Stock Non-derivative equity of Orthopediatrics Corp

Key Terms

restricted stock awards, Grant, award, or other acquisition, Form 4, Common Stock

4 terms

restricted stock awards financial

"Includes restricted stock awards totaling 15,781 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ORTHOPEDIATRICS CORP (KIDS) director Kelly Laine Fischer report on this Form 4?

Director Kelly Laine Fischer reported receiving a grant of 11,436 ORTHOPEDIATRICS CORP Common Stock shares. The award was recorded at $0.00 per share as stock-based compensation, not as an open-market purchase, and increased her directly held total to 15,781 shares.

Was the KIDS insider transaction a buy or a grant of shares?

The transaction was a grant of shares, not an open-market buy. The Form 4 classifies it as a “grant, award, or other acquisition” of 11,436 Common Stock shares at $0.00 per share, reflecting routine equity compensation for the director rather than a discretionary stock purchase.

How many ORTHOPEDIATRICS CORP shares does Kelly Laine Fischer hold after this Form 4?

After the reported grant, Kelly Laine Fischer directly holds 15,781 ORTHOPEDIATRICS CORP Common Stock shares. A footnote explains that this entire amount consists of restricted stock awards, indicating these holdings are subject to typical vesting or restriction terms rather than being fully unrestricted shares.

Does this ORTHOPEDIATRICS CORP Form 4 for KIDS show any stock sales?

The Form 4 does not report any stock sales. It shows only an acquisition classified as a grant or award of 11,436 Common Stock shares at $0.00 per share, with no dispose or sell transactions, indicating the filing is purely about updated equity compensation holdings.

What type of security was involved in the ORTHOPEDIATRICS CORP (KIDS) insider transaction?

The transaction involved Common Stock of ORTHOPEDIATRICS CORP. The director received 11,436 shares as a grant at $0.00 per share, and following this award her directly held Common Stock position, composed of restricted stock awards, totaled 15,781 shares according to the Form 4 disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fischer Kelly Laine

(Last) (First) (Middle)

2850 FRONTIER DR

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	15,781(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 15,781 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)